KSF investigates Apogee Therapeutics sale to AbbVie at $135.11 a share

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and Kahn Swick & Foti said they are reviewing whether the proposed cash consideration adequately values Apogee shareholders.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.